Clinical Trial

A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus Erythematosus

Name: A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus Erythematosus — clinical trial record (NCT07749430)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of ACG102 administered via intravenous injection in patients with refractory active systemic lupus erythematosus (SLE)

Trial Details

NCT Number	NCT07749430
Lead Sponsor	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions	Refractory Active Systemic Lupus Erythematosus
Enrollment	13 participants
Start Date	2026-09-15
Primary Completion	2027-01-30 (estimated)
Study Completion	2028-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-06